Company Filing History:
19 out of 2,078 
2 out of 363 
1 out of 377 Years Active: 2001-2014
Title: **Steven A Middleton: Innovator in Pharmaceutical Patents**
Introduction
Steven A Middleton is a prominent inventor based in Flemington, NJ, USA, with an impressive portfolio of 22 patents. His contributions to pharmaceutical innovations have significantly impacted the field of medicine, particularly in treating various disorders.
Latest Patents
Among his latest patents, Middleton has developed novel hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives, aimed at therapeutic applications for disorders mediated by the ORL-1 receptor. This invention is promising in targeting specific pathways related to various physiological conditions. Additionally, he has invented substituted pyrimidinyl oxime kinase inhibitors that hold potential for treating, preventing, or ameliorating chronic or acute protein kinase mediated diseases, disorders, or conditions. These advancements showcase his commitment to innovative solutions in the pharmaceutical industry.
Career Highlights
Middleton has had a distinguished career, collaborating with notable companies in the pharmaceutical sector. He has worked at Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation, where he has likely contributed to groundbreaking research and product development.
Collaborations
Throughout his career, Steven A Middleton has collaborated with esteemed professionals such as Peter J Connolly and Stuart Emanuel. These partnerships have undoubtedly furthered the scope of innovation in their respective projects and contributed to successful outcomes in their shared endeavors.
Conclusion
Steven A Middleton stands out as a key figure in the realm of pharmaceutical inventions and patents. His work continues to pave the way for innovative treatments, addressing critical medical needs. As he progresses in his career, his ongoing contributions will likely lead to further advancements in the health sector.